151 related articles for article (PubMed ID: 12939185)
1. [PTEN expression and its significance in human primary hepatocellular carcinoma].
Wan XW; Wang HY; Jiang M; He YQ; Liu SQ; Cao HF; Qiu XH; Tang L; Wu MC
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):490-2. PubMed ID: 12939185
[TBL] [Abstract][Full Text] [Related]
2. The alteration of PTEN tumor suppressor expression and its association with the histopathological features of human primary hepatocellular carcinoma.
Wan XW; Jiang M; Cao HF; He YQ; Liu SQ; Qiu XH; Wu MC; Wang HY
J Cancer Res Clin Oncol; 2003 Feb; 129(2):100-6. PubMed ID: 12669234
[TBL] [Abstract][Full Text] [Related]
3. [Expression of phosphatase and tensin homology deleted on chromosome ten(PTEN) and p53 protein and their significance in human hepatocellular carcinomas].
Cheng LM; Wang SY; Lin JS
Ai Zheng; 2003 Jan; 22(1):42-5. PubMed ID: 12561434
[TBL] [Abstract][Full Text] [Related]
4. Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase.
Rahman MA; Kyriazanos ID; Ono T; Yamanoi A; Kohno H; Tsuchiya M; Nagasue N
Int J Cancer; 2002 Jul; 100(2):152-7. PubMed ID: 12115563
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH
Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720
[TBL] [Abstract][Full Text] [Related]
6. [Expressions of phosphorylated-Smad2 and PTEN in hepatocellular carcinomas and adjacent liver tissues].
Wu SK; Wang BJ; Yang Y; Tian YJ; Bao JJ; Feng XH; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):567-71. PubMed ID: 17711623
[TBL] [Abstract][Full Text] [Related]
7. [Expression of PTEN, Cx43, and VEGF in hepatocellular carcinoma].
Zhang TY; An JL; Gu JY; He S
Ai Zheng; 2004 Jun; 23(6):662-6. PubMed ID: 15191666
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between the expression of PTEN protein and phosphorylation of MAPK in hepatocellular carcinomas and their surrounding liver tissues].
Feng DY; Cheng RX; Zheng H
Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):117-20. PubMed ID: 12575334
[TBL] [Abstract][Full Text] [Related]
9. Expression and significance of new tumor suppressor gene PTEN in primary liver cancer.
Dong-Dong L; Xi-Ran Z; Xiang-Rong C
J Cell Mol Med; 2003; 7(1):67-71. PubMed ID: 12767263
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of PTEN expression due to loss of promoter activity in human hepatocellular carcinoma cell lines.
Ma DZ; Xu Z; Liang YL; Su JM; Li ZX; Zhang W; Wang LY; Zha XL
World J Gastroenterol; 2005 Aug; 11(29):4472-7. PubMed ID: 16052674
[TBL] [Abstract][Full Text] [Related]
11. PTEN and hTERT gene expression and the correlation with human hepatocellular carcinoma.
Zhou X; Zhu H; Lu J
Pathol Res Pract; 2015 Apr; 211(4):316-9. PubMed ID: 25613699
[TBL] [Abstract][Full Text] [Related]
12. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
[TBL] [Abstract][Full Text] [Related]
13. Increased DJ-1 and its prognostic significance in hepatocellular carcinoma.
Liu S; Yang Z; Wei H; Shen W; Liu J; Yin Q; Li X; Yi J
Hepatogastroenterology; 2010; 57(102-103):1247-56. PubMed ID: 21410067
[TBL] [Abstract][Full Text] [Related]
14. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
15. Combined phosphatase and tensin homolog (PTEN) loss and fatty acid synthase (FAS) overexpression worsens the prognosis of Chinese patients with hepatocellular carcinoma.
Zhu X; Qin X; Fei M; Hou W; Greshock J; Bachman KE; Wooster R; Kang J; Qin CY
Int J Mol Sci; 2012; 13(8):9980-9991. PubMed ID: 22949843
[TBL] [Abstract][Full Text] [Related]
16. Expression and Prognostic Role of FHIT, Fibronectin, and PTEN in Hepatocellular Carcinoma.
Zhang MJ; Yan Q; Zhang GL; Wie YH; Yuan WB; Xu W; Huang LF
Clin Lab; 2016 Jul; 62(7):1255-1264. PubMed ID: 28164627
[TBL] [Abstract][Full Text] [Related]
17. Expression and significance of PTEN and miR-92 in hepatocellular carcinoma.
Zhao B; Zhu Y; Cui K; Gao J; Yu F; Chen L; Li S
Mol Med Rep; 2013 May; 7(5):1413-6. PubMed ID: 23546593
[TBL] [Abstract][Full Text] [Related]
18. Effects of mutation and expression of PTEN gene mRNA on tumorigenesis and progression of epithelial ovarian cancer.
Chen Y; Zheng H; Yang X; Sun L; Xin Y
Chin Med Sci J; 2004 Mar; 19(1):25-30. PubMed ID: 15104221
[TBL] [Abstract][Full Text] [Related]
19. [Expression of survivin, p27 and PTEN in hepatocellular carcinoma and their clinical significances].
Huang AM; Ding Y; Liu JF; Gao LY; Zang SB; Chen SP
Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):17-20. PubMed ID: 18226337
[TBL] [Abstract][Full Text] [Related]
20. Relationship between PTEN and VEGF expression and clinicopathological characteristics in HCC.
Mi D; Yi J; Liu E; Li X
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):682-5. PubMed ID: 17357488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]